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Abstract
This paper seeks to unveil the niche of delay differential equation in harmonizing low
HIV viral haul and thereby articulating the adopted model, to delve into structured
treatment interruptions. Therefore, an ordinary differential equation is schemed to
consist of three components such as untainted CD4+ T-cells, tainted CD4+ T-cells
(HIV) and CTL. A discrete time delay is ushered to the formulated model in order to
account for vital components, such as intracellular delay and HIV latency which were
missing in previous works but have been advocated for future research. It was
divested that when the reproductive number was less than unity, the disease free
equilibrium of the model was asymptotically stable. Hence the adopted model with
or without the delay component articulates less production of virions as per the
decline rate. Therefore CD4+ T-cells in the blood remains constant at δ1/δ3, hence
declining the virions level in the blood. As per the adopted model, the best STI
practice is intimated for compliance.
Keywords: Cytotoxic Lymphocytes; Structured treatment interruption; Disease free
Equilibrium: Human immunodeficiency virus; Basic reproductive number
1 Introduction
Comparatively, HIV like most viruses is very minute, unadorned organism which cannot
reproduce unaided. It remains the most deadly disease [1] which has ever hit the planet
since the last three decades. However, as the fight for survival between the virus and the
human immune system persist [1–7], CD4+ T-lymphocytes and macrophage remediate
the cellular defence mechanism of the body. The immune system [1, 7–14], congregates
to filter diverse information from invading pathogens and perceives them through the T
cell receptors (TCRs) (Fig. 1).
1.1 Modelling of intracellular delay
Delay differential equations (DDEs) have been valuable for innumerable years in control
theory and recently interrelated to biological and mathematical models. Most biological
frames [10] have time delay embedded in them, yet few scientist collaborate them due
to the intricacies they stimulate. The principal intricacies in studying DDEs lie in their
solitary transcendental character.
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Figure 1 Specialized Macrophage cell which ingest foreign antigens invading the host cell
In this paper, we first formulate a system of ordinary differential equations expounded
as follows
dx
dt = a1(1 – xy – x),
dy
dt = a2(a3xy – y) – a4yz, (1.1)
dz
dt = a5(y – z),
where CD4+ T-cell is symbolized as (x), tainted cells as (y) and CTL as (z).
Next, we define a translation operator Tτ where τ ≥ 0, and Tτ (T) = s(t – τ ). Therefore
by nominal convenience x1 := Tτx, y1 := Tτ y, and z1 := Tτ z, hence we express the system
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of equations with delay as follows
⎧
⎪⎪⎨
⎪⎪⎩
dx
dt = a1(1 – xy – x),
dy
dt = a2(a3x1y1 – y) – a4yz,
dz
dt = a3(y – z).
(1.2)
The term a2a3x1y1, represents the rate equation and reflects a boundless time lag be-
tween the infection of CD4+ T-cell and the staging of new virions. Next we consider the
well posedness and existence of equilibrium points.
2 Well posedness and existence of equilibrium points
We define equation (1.2) in terms of F, G and H as shown below;
dx
dt = F(x, y, z,x1, y1, z1),
dy
dt =G(x, y, z,x1, y1, z1), (2.1)
dz
dt =H(x, y, z,x1, y1, z1).
Equating (1.2) and (2.1), yields
F(x, y, z,x1, y1, z1) := a1(1 – xy – x),
G(x, y, z,x1, y1, z1) := a2(a3,x1, y1 – y) – a4yz, (2.2)
H(x, y, z,x1, y1, z1) := a5(y – z).
Further, we define a steady state for equation (2.2) in terms of (x, y, z) and procure the
equations below:
F(x, y, z,x1, y1, z1) = 0,
G(x, y, z,x1, y1, z1) = 0, (2.3)
H(x, y, z,x1, y1, z1) = 0.
Proposition 2.1 If a2a3 and z1 := Tτ z, then the steady state solution of equation (2.1) is in
unison with the steady state solution of equation (2.3).
Proof Consider an immutable function S(t) and its derivative dsdt , assuming that the deriva-
tive of the function is dsdt =
ds1
dt , then:
F(x, y, z,x1, y1, z1) = 0, G(x, y, z,x1, y1, z1) = 0 and H(x, y, z,x1, y1, z1) = 0,
hence equations (2.1) and (2.3) have the same unvarying states.
Further, by codifying a neighborhood close to the unvarying state solution, we let
x = x +X, y = y + Y , z = z + Z, x1 = x +X1,
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y1 = y + Y1 and z1 = z + Z1.
Next, we exploit the Taylor series about the point (x, y, z) and withholding only the linear
terms yields
dX
dT = –a1(y + 1)X – a1xY ,
dY
dt = a2a3yX1 +
[
a2(a3xY1 – Y ) – a4zY
]
– a4yZ and (2.4)
dZ
dt = a5Y – a5Z.
Further, we linearized equation (2.4) as:
⎢
⎢
⎢
⎢
⎣
dX
dt
dY
dt
dZ
dt
⎥
⎥
⎥
⎥
⎦ =
⎢
⎢
⎢
⎢
⎣
–a1(y + 1) –a1x 0
a2a3ye–λt a2(a3xe–λt – 1) – a4z –a4y
0 a5 –a5
⎥
⎥
⎥
⎥
⎦
⎢
⎢
⎢
⎢
⎣
X
Y
Z
⎥
⎥
⎥
⎥
⎦ . (2.5)
Next we let
B =
⎢
⎢
⎢
⎢
⎣
–a1(y + 1) –a1x 0
a2a3ye–λt a2(a3xe–λt – 1) – a4z –a4y
0 a5 –a5
⎥
⎥
⎥
⎥
⎦ .
Where B is the coefficient matrix of the linearized system and λ is the eigenvalue of
matrix B. Hence the unvarying state of the delay system can be explored in terms of the
eigenvalues of matrix B. 
3 Global stability of equilibrium EO
In this section, we proceed by analyzing the universal stability of the disease-free equilib-
rium of the model. Hence we let (xo, yo, zo) be an unvarying state solution of the following
equations: dxdt = F(x, y, z,x1, y1, z1),
dy
dt = G(x, y, z,x1, y1, z1) and
dz
dt = H(x, y, z,x1, y1, z1), then
(xo, yo, zo) is stable if  > 0 and δ > 0 for (x, y, z) when
[
x(to) – xo
]2 +
[
y(to) – yo
]2 +
[
z(to) – zo
]2 < δ2. (3.1)
Given that to ∈ [t1 – τ , t1], then [x(t) – xo]2 + [y(t) – yo]2 + [z(t) – zo]2 < ε2 for all t > t1.
On the other hand if (xo, yo, zo) is stable and δ is chosen so that equation (3.1) is elucidated
as [x(t), y(t), z(t)→ (xo, yo, zo)]. Then as t → ∞, (xo, yo, zo) is globally asymptotically stable.
Proposition 3.1 Suppose a1,a2,a3,a5 > 0:
(i) Then if a3 < 1, then the unvarying state of equation (1.2) of the system (2.1) is
universally asymptotically stable for τ ≥ 0. Hence EO is stable.
(ii) If a3 > 1,then the unvarying state of equation (1.2) of the system (2.1) is globally
unstable, hence EO is unstable.
Proof Suppose the characteristic equation of matrix B is written as
U(λ) = λ3 + b1λ2 + b2λ + b3 +
(
d1λ2 + d2λ + d3
)
e–τλ = 0. (3.2)
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Now if τ = 0, then there is no delay in equation (3.2), hence Proposition 3.1 reduces to
Proposition 2.1.
Conversely, when τ > 0, andwe surrogate the unvarying state of equations (1.2) and (2.2)
and solve, we generate the characteristic equation
(λ + a1)
(
λ + a2 – a2a3e–λτ
)
(λ + a5) = 0.
Next, by considering the unvarying state of equation (1.2), we ascertain that matrix B
has three eigenvalues: λ1 = –a1 < 0,λ2 = –a5 < 0 and λ3 in the form
λ3 + a2
(
a3e–τλ3 – 1
)
= 0.
Therefore, to find the location of λ3, we propose a function of the form
u(t) := t + a2 – a2a3e–λτ , where t ∈ R.
By differentiating, we obtain u′(t) = 1 + a2a3τe–λτ , which is always positive, hence the
limit of the original equation is written as limt→∞ u(t) = –∞ and limt→∞ u(t) =∞. There-
fore u(t) has a distinctive zero revealed as u(0) = a2(1 – a3). Hence we conclude that if
a3 < 1,u(0) > 0 and λ3 < 0. Then the unvarying state of equation (2.5) is globally asymptot-
ically stable for τ > 0.
Conversely if a3 > 1,then we conclude that the unvarying state of equation (1.2) is glob-
ally asymptotically unstable for a3 < 0, λ3 > 0 and τ > 0. 
4 The endemic equilibrium
The endemic equilibrium E∗ is obtained by filtering the real and imaginary parts from the
equation below
[b3 + b2α + b1α2 + α3 – b1ω2 – 3αω2 + i
(
b2ω + 2b1αω + 3α2ω –ω3
)
+ e–τα[(d2ω + 2d1αω) sinωτ +
(
d3 + d2α + d1α2 – d1ω2
)
cosωτ
+ ie–τα
[(
d1ω2 – d3 – d2α – d1α2
)
sinωτ + (d2ω + 2d1ω) cosωτ
]
= 0, (4.1)
which yields
d2ω sinωτ +
(
d3 – d1ω2
)
cosωτ = b1ω2 – b3, (4.2)
d2ω cosωτ –
(
d3 – d1ω2
)
sinωτ = ω3 – b2ω. (4.3)
Summing the squares of equations (4.2) and (4.3)
u(ω) := ω6 +
(
b21 – 2b2 – d21
)
ω4 +
(
b22 – 2b1b3 + 2d1d3 – d22
)
ω2 + b23 – d23 = 0. (4.4)
We further exploit equation (4.4) by surrogating the parameters below
m := ω2, p := b21 – 2b2 – d21, q := b22 – 2b1b3 + 2d1d3 – d22 and r := b23 – d23.
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Hence, the new equation reads
k(m) =m3 + pm2 + qm + r = 0. (4.5)
Lemma 4.1 Suppose τ > 0 then equation (4.5) has no positive real root, hence all the roots
have negative real parts.
Proof Since equation (4.5) has no positive root, then ω is not the root of equation (4.4).
Therefore for any real number ω, the value of iω is also not the root of equation (4.4),
hence λ(τc) = iω(τc) is not the root of equation (4.4). This implies that only one positive
real root exist for equation (4.5). Hence differentiating equation (4.5) yields
k′(m) = 3m2 + 2pm + q. (4.6)
Therefore the roots of equation (4.5) are
mo =
–p +
√
p2 – 3q
3 and
–p –
√
p2 – 3q
3 . 
Lemma 4.2
(i) If r < 0 then it follows that p2 – 3q > 0 has a positive root, provided p < 0.
(ii) On the other hand if r > 0 then p2 – 3q < 0, has no positive real roots.
Proof (i). Suppose condition (i) holds and r < 0, then k(0) = r < 0, hence limm→∞ k(m) =∞.
Exploiting the intermediate value theorem, equation (4.6) yields to as a positive root and
therefore k(to) = 0.
Conversely, if condition (ii) holds for which r > 0 and p2 – 3q < 0, then mo is real for
which mo > 0. Since k(0) = r > 0 and k(mo) < 0, then by the intermediate value theorem, k
has zero between the origin andmo
(ii). conversely, if q > 13p2 then the zeros ofmo andm1 of K ′(m) are not real. Henceforth
K ′(m) = 0 has no real root.
Consequently q > 13p2 ≥ 0, has no real roots, given thatK is an increasing functionwhere
K(0) = r ≥ 0. We conclude that the model has a unique endemic equilibrium which is
asymptotically stable if and only if Ro > 1, otherwise unstable. This unique endemic equi-
librium occurs at τ ≥ 0. 
5 Existence of Hopf bifurcation
We introduce the Hopf bifurcation and therefore appraise the 3-dimensional system of
differential equations as follows
dx
dt = F(x, y, z, τ ),
dy
dt =G(x, y, z, τ ), (5.1)
dy
dt =H(x, y, z, τ ).
The following conditions holds if:
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(i) F(x, y, z, τ ) =G(x, y, z, τ ) =H(x, y, z, τ ) = 0, then τc and (x, y, z, ) remains as a steady
state solution for equation (4.5).
(ii) F, G and H are analytic in terms of (x, t, z), then they are within the neighborhood of
(x, y, z, τc).
(iii) the Jacobian matrix of equation (2.5) at (x, y, z, τ ) has a pair of complex conjugate
eigenvalues, λ and λ, then
λ(t) = α(τ ) + iω(τ ), ω(τc) = ωc > 0, α(τc) = 0 and
dα(τ )
dr Iτ = τC = 0.
(5.2)
(iv) the remaining eigenvalues of the Jacobian matrix at (x, y, z, τc) have strictly negative
real part. Then the system (4.1) has a family of periodic solution: εH > 0 and
analytic function τH () =
∑
2 ∞THi εi, where 0 < ε < εH . Hence, TH (ε) of pε(t) is
analytic and of the form
TH (ε) = 2π
ωc
(
1 +
∞∑
2
THi εi
)
(0 < ε < εH ). (5.3)
Next, we exploit the parameters of the analytic function to ensure the occurrence of
Hopf bifurcation. Hence we denote the positive roots of equation (4.1) by mj, j, where
j ∈ [0, 1, 2], depending on the number of positive roots in the equation. Therefore equation
(4.1) has six positive roots such as ωj,λ = iω and ±√mj where j = 0, 1, 2. Consequently,
substituting ωj into equation (4.2) and (4.3) and solving for τ produces
τ
(n)
j =
1
ωj
arcsin
⌈d1ω5j + (b1d2 – d3 – d1b2)ω3j + (d3b2 – b3d2)ωj
d22ω2j + (d3 – d1ω2j )2
⌉
+ 2π (n – 1
ωj
. (5.4)
Where j = 0, 1, 2 and n = 1, 2, . . . .
Again, when we consider τc > 0 to be a smaller value, where α(τc) = 0, then
τcT (nc)jc = min
{
τ
(τ )
j > 0, 0≤ j ≤ 2,n≥ 1
}
. (5.5)
Where ωc = ωjc.
Theorem5.1 Consider the time lag τ and the critical time lag τc andωc as defined in equa-
tion (4.5) and suppose 3ω6c +2pω4c +qω2c = 0 then the system of delay differential equation in
terms of equation (2.1), portrays the Hopf bifurcation at the steady state in equation (1.2).
Proof We show that
dα(τ )
dτ Iτ = τC = 0. (5.6)
The existence of Equation (4.6) personifies the occurrence of Hopf bifurcation. Hence
equating the real and imaginary parts of equations (4.2) and (4.3) to zero, we obtain the
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following
e–τα
[
(d2 + 2d1α)ω sinωτ +
[
(d3 + d2α + d1
(
α2 –ω2
)]
cosωτ
]
= (b1 + 3α)ω2 – b3 – b2α – b1α2 – α3] (5.7)
and
e–τα
[(
d1ω2 + d3 – d2α – d1α2
)
sinωτ + (d2ω + 2d1αω) cosω
]
= ω3 – b2ω – 2b1αω – 3α2ω. (5.8)
Further, we differentiate equations (5.7) and (5.8) with respect to τ and evaluate at τ = τc
where ατc = 0 and ω(τc) = ωc and obtains the following
E1
dω
dτ
∣
∣
∣
∣τ = τc – E2
dα
dτ
∣
∣
∣
∣τ = τc = E3 cosωcτc + E4 sinωcτ ,c , (5.9)
E2
dω
dτ
∣
∣
∣
∣τ = τc – E1
dα
dτ
∣
∣
∣
∣τ = τc = E3 sinωcτc + E4 cosωcτc. (5.10)
Where E1 := 2b1ωc + (2d1ωc – τcd2ωc) cosωcτc + (τcd3 – d2 – τcd1ω2c ) sinωcτc, E2 := b2 –
3ω2c + (d2 + τcd1ω2c – τcd3) cosωcτc + (2d1ωc – τcd2ωc) sinωcωc, E3 := d2ω2c and E4 := d1ω3c –
d3ωc.
Now by solving equations (5.9) and (5.10) together we have
dα
dτ
∣
∣
∣
∣τ = τc =
(E1E4 – E2E4) sinωcτc – (E1E4 + E2E3) cos τc
E21 + E22
. (5.11)
Next we substitute equations (4.2) and (4.3) into equations (5.9) and (5.10) and yields
cosωcτc =
(b1ω2c – b3)(d3 – d1ω2c + d2ωc(ω3c – b2ωc)
d22 + (d3 – d1ω2c )2
, (5.12)
sinωcτc =
d2ωc(b1ω2c – b3) – (d3 – d1ω2c )(ω3c – b2ωc)
d22ω2c + (d3 – d1ω2c )2
. (5.13)
Finally, we incorporate equations (5.12) and (5.13) into equation (5.11) and obtains
dα
dτ
∣
∣
∣
∣τ = τc =
3w6c + 2pω4c + qω2c
E21 + E22
= 0. (5.14)
Consequently we conclude based on equations (5.12), (5.13) and (5.14), the existence of
Hopf bifurcation when, τ passes through the critical value τc. 
5.1 Proof for the existence of Hopf bifurication
In this section we prove the existence of Hopf Bifurcation by assuming that a1,a2,a5 > 0
and a3 > 1, for τc and ωc as defined in equation (4.6). Therefore by Lemma 4.2(i) if
p≥ 0,q ≥ 0, then we conclude that the system of delay differential equations proposed in
equation (2.1) for the whole delay process has Hopf bifurcation. Consequently, the Hopf
bifurcation occurs at p ≥ 0,q ≥ 0, when 3w6c + 2pω4c + qω2c = 0. This is further supported
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Figure 2 Demonstration of the forward bifurcation process of the model with τ against τc : where τc = qωc ,
ωc = 0.024,P = 1000,q = 2200, E1 = 0.029 and E2 = 0.06
by Lemma 4.1 and Theorem 5.1. The forward bifurcation analysis is portrayed by Fig. 2,
where τ = qωc, ωc = 0.024,P = 1000,q = 2200,E1 = 0.029 and E2 = 0.06. The conditions for
the existence of Hopf bifurcation have been extrapolated by the above analysis. Hence,
Fig. 2 portrays the conditions for the model to have a forward bifurcation under a single
endemic equilibrium.
6 Numerical simulation
The numerical simulations are engaging around the convergence of orbits of the global
stability and the existence of Hopf bifurcation for the system (5.14). The results are en-
joined to flaunt the effects of intracellular delay on the qualitative behavior of the three
variables: CD4+ T-cell, symbolized (x), cells tainted with HIV, symbolized (y) and CTL,
symbolized (z) [7, 14].
Firstly, the model was analyzed without the delay component embedded (ODE), under
the following conditions: affirmation of the qualitative conduct of the three variables such
as CD4+ T-cell (x), HIV (y), and CTL (z). The affirmation of the three variables was done
alongside with controlling the fundamental reproductive rate of the virus. Therefore when
equation (1.1) was solved numerically as per the 6th order Runge–Kutta strategy with a1 =
0.224,a2 = 0.941,a3 = 0.369,a4 = 4.651,a5 = 1.311. It was ascertained that the quantum
of CD4+ T-cells were consistent over time, whilst CTL and the virus level in the blood
approaches zero (Fig. 3). In relation to Proposition 3.1(i) and equation (1.1), when a3 <
1, a steady state was attained at (1, 0, 0). Therefore the conceptive pace of the infection
happens to be under control and hence the decline rate of viral production is higher than
the production rate. The virus at this stage cannot spread and hence eliminated from the
blood as the quantum of CD4+ Tcells remains constant at δ1/δ3 (Fig. 3).
On the contrary, the model was further analyzed with the delay component (DDE),
under the following conditions: affirmation of the qualitative conduct of the three vari-
ables such as CD4+ T-cell (x), HIV (y), and CTL (z). The affirmation of the three variables
was done alongside with controlling the fundamental reproductive rate of the virus. Next
equation (1.2) was solved numerically using the 6th order Runge–Kutta technique where
Owusu et al. Advances in Difference Equations        (2020) 2020:401 Page 10 of 19
Figure 3 (a), (b), (c), (d) shows the Numerical simulation of the model without the delay component. Figure
(a) shows how the quantum of CD4+ T-cells approaches zero, while (b) and (c) shows the amount of HIV and
CTL in the blood respectively. Figure (d) shows how the virus component decreases over time as CTL
approaches zero
a1 = 0.224,a2 = 0.941,a3 = 0.369,a4 = 4.651, τ = 0.191. It was ascertained that the quan-
tum of CD4+ T-cells were consistent over time, whilst CTL and the virus level in the blood
approaches zero (Fig. 4). In relation to Proposition 3.1(i) and equation (1.2), when a3 < 1,
a steady state was attained at (1, 0, 0). Therefore the conceptive pace of the infection hap-
pens to be under control and hence the decline rate of viral production is higher than the
production rate. The virus at this stage cannot spread, hence eliminated from the blood
as the quantum of CD4+ T-cells remains constant at δ1/δ3 (Fig. 4).
The model with delay was more advantageous over the non-delay model, because it
was more stable at the trajectory. It supports viral peak postponement and virological
suppression better than the non-delay (Figs. 3 and 4).
Another dimension to the analysis was the removal of the delay component under the
following conditions: affirmation of the qualitative conduct of the three variables such as
CD4+ T-cell (x), HIV (y), and CTL (z). This time the fundamental reproductive rate of the
virus was uncontrolled. Now when equation (1.1) was solved numerically as per the 6th
order Runge–Kutta strategy with now a1 = 0.1038,a2 = 3.22,a3 = 2.64,a4 = 7.41,a5 = 4.17.
The density of HIV and CTL approaches the vanishing point to confirm the connection
between the virus and the immune response, as depicted in Fig. 5. This implies that the
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Figure 4 (a), (b), (c), (d) shows the Numerical simulation of the model with the delay component system.
Figure (a) shows how the quantum of CD4+ T-cells approaches a constant value whilst (b) and (c) shows how
the quantum of HIV decreases whilst CTL remains constant over time. Figure (d) shows how the virus
component decreases over time as CTL in the blood weakens and approaches zero
essential conceptive pace of the infection is not under control and hence the decline rate of
viral production is lower than the production rate. Infection rate surges and more virions
are produced in the blood (Fig. 5).
Contrary to the above, themodel was analyzed furtherwith the delay component (DDE),
under the following conditions: affirmation of the qualitative conduct of the three vari-
ables such as CD4+ T-cell (x), HIV (y), and CTL (z). The fundamental reproductive rate
of the virus was uncontrolled and equation (1.2) was solved numerically using the 6th or-
der Runge–Kutta technique where a1 = 0.1038,a2 = 3.22,a3 = 2.64,a4 = 7.41, τ = 0.19. It
was observed that the essential conceptive pace of the infection was not under control
and hence the decline rate of viral production was lower than the production rate (Fig. 6).
Therefore the elongation of the infection [2, 3, 13] on an individual leads to the inception
of AIDS.
7 Structured treatment interruption
The quest for legit structured treatment interruptions has necessitated the essence of in-
tracellular delay in STI models. Currently, the adopted STI used by many HIV individuals
does not incorporate days-off for drug assimilation by the body. Arguably therapy inter-
Owusu et al. Advances in Difference Equations        (2020) 2020:401 Page 12 of 19
Figure 5 (a), (b), (c), (d) shows the numerical simulation of the model without the delay component and the
reproductive number is not constant. Figure (a), the quantum of CD4+ T cells approaches a constant value:
(b) and (c) shows how HIV and CTL component in the blood fluctuates before assuming a common point,
with time. Figure (d) depicts an escalation of the virus as CTL level decreases drastically
ruptions should align across days and weeks, in order to allow for drug assimilation. Find
below some of the STI systems embedded to validate the model.
7.1 Two-weeks-on two-weeks-off strategy (14/14)
The scenario above relates to 14 days on treatment and 14 days off regime therapy, de-
signed for HIV patients. However, adherence to the regime yields an auto viral control
compared to the primitive STI system [11], which aligns with lengthy periods of therapy.
In reference to Fig. 7, this strategy yields a momentous average viral load of 586 virions/ml
and 3371 virions/m at peak level. On the contrary, a continuous therapy without any in-
terruption increases the viral haul to 633 virions/ml on the average. This implies that the
shorter the period for a particular therapy, the lower the peak viral haul. Therefore the
lower the peak viral haul, the less the augmentation of viral strains, responsible for drug
resistance mutations (Fig. 7).
Further, the graphs also deal with non-delay and therefore an average viral haul of
8446 virions/ml was produced (Fig. 7(b)). The amount of virions produced by the non-
delay therapy was higher and therefore signals the essence of delay. Hence, with reference
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Figure 6 (a), (b), (c), (d) shows the numerical simulation of the model with delay whilst the reproductive
number is not constant. Figure (a) shows how the quantum of CD4+ T cells decreases over time and assume
a constant value: Figure (b) and (c) shows fluctuations of HIV and CTL in the blood. The Virus has reached an
uncontrollable state as CTL decreases. Figure (d) shows an escalation of the virus component whilst CTL
diminishes drastically for the interception of HIV
to the ongoing discussion, a short cycle therapy is recommended on the basis of control-
ling viral rebound.
7.2 Five-days-on two-days-off strategy (5/2)
The five days on and two days off STI strategy allows treatment from Monday to Friday,
with Saturday and Sunday as weekends off treatment. This strategy, also inferred as week-
end off strategy is vital in subduing long term viral replication [1, 11]. It enhances a de-
crease in drug residual level, since its squatty intermission period allows for the assimi-
lation of DRM. Hence in curbing down monotherapy situations, the usage of particular
drugs should be disengaged for suitable metabolism rate.
In addition, the five days on and two days off regime, supports a decline of themaximum
viral haul. It is worth to note that escalations in viral haul have been a headache for most
scientists. The peak viral haul is crucial and personifies a larger viral pool which begets
mutations. Based on the 5/2 strategy a cost saving of 29% is marginalized, compared to the
continual therapy. In addition, the 5/2 strategy produces low viral haul due to limited viral
rebound. Furthermore, the strategy is useful to places where therapy is not consistent and
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Figure 7 Graphs of STI which shows 14 days on and 14 days off treatment
hence reliable to stop therapy for two days, than to abort the whole process due to limited
drug availability. In accordance with the above discussions, the 5/2 strategy appears to be
reasonably successful in producing positive results [1, 11], as depicted by Fig. 8.
From Fig. 8, the 5 days on and two days off therapy induces a mean viral haul of 331 viri-
ons/ml with zero delay and 412 virions/ml within 24 hours.
7.3 Impact of varying the on and off period
The idea of varying treatment on and off has conceited imperative due to less access to
ARV, cost concerns and ceaseless treatment. However off-treatment should not be pro-
longed due to high viral rebound and viral mutation to drugs.
This chapter contrasts the 5/2 system, the 20/8 system and the 26/2 system and suggest
the way forward. The ceaseless treatment period was used as reference and therapy was
tempered as per the three systems above (Fig. 9). It was observed that tempering with
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Figure 8 Demonstrates the 5 days on and 2 days off therapy
therapy for a short period of time was essential due to the following reasons: accessibility
to ARV, cost concerns and discontinuity of therapy due to ARV shortage. Therefore the
shorter the time frames for off treatment, the better the results and the lesser the viral
rebound [11–14].
In accordance with the ongoing analysis, it was ascertained that the 26/2 system (Ta-
ble 1) stimulates a reliable outcome, however the system is not decisive due to its little
cost sparing of about 7%. On the other side, the 20/8 system appears to have a lower viral
haul than the 5/2 system. The respective average and peak viral hauls for the 20/8 sys-
tem were 352 virions/ml and 751 virions/ml respectively. The 5/2 system also articulated
437 virions/ml and 756 virions/ml respectively. In view of the above outcome a trade-
off is simulated to enhance the choice and adoption of a suitable treatment interruption
(Fig. 9). Therefore the next section enhances the selection of the overall regime for com-
pliance.
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Figure 9 Correlation of the 5/2, 20/8 and 26/2 STI Regime
7.4 Overall STI regime comparison
The above examination has conceited essential in adjusting treatment on and off, thereby
diminishing the pinnacle viral haul. Therefore, based on the above analysis the 18/3 and
24/4 systems have been recommended for compliance and adoption due to low viral haul
production (Fig. 10). The 18/3 system produces an average and peak virions of 120 and
285 virions/ml respectively, whilst the 24/4 system produces 118 and 338 virions/ml re-
spectively (Fig. 10).
8 Conclusion
The aimof the paper is to unveil the niche of delay differential equation in harmonizing low
level HIV viral haul and thereby articulating the adopted model to delve into structured
treatment interruptions.
Hence, the sturdiness of the model with delay (equation (1.2)) and without delay (equa-
tion (1.1)) was assessed. Numerical simulations were used to consolidate the results.
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Table 1 Demonstration of treatment strategies, viral load level and corresponding cost
Strategy on/off days Average Viral haul Virions/ml Peak Viral haul % Cost Saving Virions/ml
5/2 437 756 29
12/2 126 320 14
11/3 209 623 21
19/2 86 171 10
18/3 120 285 14
17/4 168 465 19
20/8 352 751 24
26/2 70 138 7
25/3 92 218 11
24/4 118 338 14
23/5 151 507 18
22/6 201 743 21
21/7 558 1086 25
30/5 114 408 14
36/6 121 495 14
42/7 117 610 14
The demands for the stability of Hopf bifurcation were authenticated in itemizing the
initial conditions of the model (Fig. 2). The existence of Hopf bifurcation [3, 4] has been
proved and hence occurs when, τ passes through the critical value τc.
The analysis of the results indicated that when the basic reproductive rate of the virus
was under control and the delay component τ were embedded in the model to verify the
qualitative behavior of the three variables, such CD4+ Tcells (x), HIV cells (y) and CTL
(z). It was concluded that when a3 < 1, then by Proposition 3.1(i): a steady state exists at
(1,0, 0). Therefore the pace of infection by the virus is under control and the decline rate
of viral production is higher than the production rate at δ1/δ3
Conversely when a3 > 1, then as per Proposition 3.1(ii): a non-existence steady state
occurs. Therefore the pace of the contagion is higher than the decline rate at δ1/δ3 and
AIDS intercepts. [2]
Adherence to the conditions imposed on Proposition 3.1(i) when a3 < 1, intimates that
the reproductive ratio of the virus is under control. This signifies a stable CD4+ T cells,
hence adherence to therapy could delay AIDS interception. Further, by the conditions of
Proposition 3.1(i) we have revealed an abortive attempt by the virus due to the consistent
increase in CD4+ T cells (Fig. 4). Hence, CTL consequently eliminates the virus from the
body. This is made possible when CD4+ T cells converges at δ1/δ3
Again sustenance of the imposed conditions on Proposition 3.1(i), is central to viro-
logical suppression and increased life expectancy under HIV [9, 11, 14]. Therefore it is
imperative to ascertain the time frame, for the adaptive immune response of the body to
emerge in regulating viral replication. This is supported when a3 < 1.
Further, in compliance with the rigorous analysis imposed on treatment options, the
study hereby recommends for a short period off medication. This certifies that treatment
should be expelled for only few days to allow for drug assimilation [8]. Therefore in refer-
ence to the imposed interactions on STI systems, the study recommends for the 24 days
on treatment and 4 days off treatment for compliance. 18 days on treatment and 3 days off
treatment is also supported by the study. [8, 12]
Notwithstanding, due to increased imposition on treatment interruptions the study rec-
ommends for the application of controlled techniques to enhance the adopted model.
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Figure 10 Comparison of the STI systems; (24/4, 21/3, 12/2)
Finally, the use of optimal control with distributed delay could also be exploited due to
increase in target cells complexities [6].
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